Cargando…
Efficacy and safety of cross-linked hyaluronic acid single injection on osteoarthritis of the knee: a post-marketing Phase IV study
PURPOSE: The primary objective of this study was to evaluate the efficacy, safety, and duration of action of viscosupplementation with Crespine(®) Gel over a 9-month period. MATERIALS AND METHODS: The study was a post-marketing Phase IV study. A total of 109 participants with osteoarthritis of the k...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396588/ https://www.ncbi.nlm.nih.gov/pubmed/25897212 http://dx.doi.org/10.2147/DDDT.S81524 |
Sumario: | PURPOSE: The primary objective of this study was to evaluate the efficacy, safety, and duration of action of viscosupplementation with Crespine(®) Gel over a 9-month period. MATERIALS AND METHODS: The study was a post-marketing Phase IV study. A total of 109 participants with osteoarthritis of the knee (grades 1–4) in the tibio–femoral compartment were recruited in Jordan. Data were collected from each participant during the baseline visit. Each participant received Crespine(®) Gel injection, and follow-up visits took place at 3 months, 6 months, and 9 months post-injection. MAIN OUTCOME MEASURE(S): An assessment of participants by phone was conducted at 1 month, 2 months, 4 months, 5 months, 7 months, and 8 months post-injection. Western Ontario and McMaster Universities Arthritis Index questionnaires were completed during each visit. A 72-hour visit questionnaire was used to assess the safety of the injection. Statistical analysis included a two-sided 95% confidence interval for the difference between pain scores across visits, and the percent change from baseline was calculated. MAIN RESULTS: The full analysis included 84 participants who gave their informed consent and finished the necessary baseline and follow-up visits needed to assess efficacy and safety. Peak improvement was noted at 5 months post-injection, when pain and physical performance scores had decreased to 2.60 and 9.90, respectively, and the stiffness score was 0.33. The peak improvement in stiffness was noted at 8 months post-injection, when the stiffness score had decreased to 0.32. Significant improvements were still apparent at 9 months post-injection, when the pain score was 3.36, the stiffness score was 0.42, and the physical performance score was 11.5. All side effects were local and transient, and included pain, swelling, and redness of the knee. Most side effects were treated. CONCLUSION: Hyaluronan should be encouraged as an alternative or adjunct treatment to oral analgesics to reduce their required doses, and delay potential future surgical intervention. |
---|